Recombinant Human cAMP-dependent Protein Kinase Inhibitor β/PKI-β (N-6His)

Recombinant Human cAMP-dependent Protein Kinase Inhibitor β/PKI-β (N-6His)

SKU: C247-10ug
Recombinant Human PKI-beta is produced by our E.coli expression system and the target gene encoding Met1-Lys78 is expressed with a 6His tag at the N-terminus. Bon Opus Cat. #C247
  • Accession Number

  • Background

    cAMP-Dependent Protein Kinase Inhibitor β (PKI-β) is a member of the PKI family. It has been shown that PKI-β is an extremely potent competitive inhibitor of cAMP-dependent protein kinase activity; this protein interacts with the catalytic subunit of the enzyme after the cAMP-induced dissociation of its regulatory chains.
  • Expression

    E. coli
  • Packaging

    Dry ice/Polar packs
  • Formulation

    Supplied as a 0.2 μm filtered solution of 20mM TrisHCl, 100mM NaCl, 1mM DTT, 20% Glycerol, pH 8.0.
  • ALTnames

    cAMP-Dependent Protein Kinase Inhibitor Beta, PKI-beta, PKIB, PRKACN2
  • Twitter
  • Facebook
  • LinkedIn

Terms and Conditions  I  Privacy Policy  I  Legal  I  Sitemap ©2020 by Bon Opus Biosciences, LLC.     150 Essex St, Millburn, NJ 07041, USA